CIK 0001709941
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474721157
- Phone
- +1 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- 4 Planned sale Chief Executive Officer sold 233,107 shares at $18.12 ($4,223,036)
- 4 Planned sale Chief Medical Officer sold 7,433 shares at $12.85 ($95,490)
- 4 Planned sale Chief Medical Officer sold 18,000 shares at $12.00 ($216,000)
- 4 Planned sale Chief Medical Officer sold 68,897 shares at $10.19 ($701,909)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 3,000 shares at $18.00 ($54,000)
- 4 Open-market buy Principal Accounting Officer bought 2,632 shares at $18.00 ($47,376)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 219,195 shares at an average $19.75 ($4,329,019)
Page 2 of 4 · 61 filings